Cyclosporine for Plaque-Type Psoriasis
- 31 January 1991
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 324 (5) , 277-284
- https://doi.org/10.1056/nejm199101313240501
Abstract
Severe plaque-type psoriasis has been successfully treated with orally administered cyclosporine, but there has been no comparative, controlled evaluation of various dosages and their efficacy and side effects.Keywords
This publication has 33 references indexed in Scilit:
- Renal effects of cyclosporineJournal of the American Academy of Dermatology, 1990
- Management of patients and side effects during cyclosporine therapy for cutaneous disordersJournal of the American Academy of Dermatology, 1990
- Intralesional cyclosporine in the treatment of psoriasis: A clinical, immunologic, and pharmacokinetic studyJournal of the American Academy of Dermatology, 1990
- Cyclosporine therapy for psoriasis: Serum creatinine measurements are an unreliable predictor of decreased renal functionJournal of the American Academy of Dermatology, 1989
- Central Nervous System Toxicity after Liver TransplantationNew England Journal of Medicine, 1987
- Treatment of resistant severe psoriasis with systemic cyclosporineJournal of the American Academy of Dermatology, 1987
- INDUCTION OF CONTRACTION IN ISOLATED RAT AORTA BY CYCLOSPORINETransplantation, 1987
- Inflammatory and Immune Cell Function in Psoriasis—A Subtle Disorder I. In Vivo and In Vitro SurveyJournal of Investigative Dermatology, 1978
- Immunological Studies in PsoriasisDermatology, 1977
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976